HOME > BUSINESS
BUSINESS
- Taiho’s Lonsurf Grabs US Priority Review Status for Gastric Cancer
October 29, 2018
- Daiichi Sankyo, Merck KGaA, Pfizer to Collaborate for PI of DS-8201, Bavencio, and DDR Combo
October 29, 2018
- Lemborexant Improves Nighttime Activity in AD Patients with Irregular Sleep-Wake Rhythm Disorder in PII: Eisai
October 29, 2018
- Eisai, Biogen Tout BAN2401’s Clinical Effect Regardless of APOE4 Mutation
October 29, 2018
- Shionogi, Osaka Univ. to Collaborate on Medical Data Science for Effective Use of Real-World Data
October 26, 2018
- Eisai to Offer 3 Rounds of Voluntary Retirement Program, to Cut 100 Jobs in March Next Year
October 26, 2018
- Xofluza Bags US Approval: Shionogi
October 26, 2018
- Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
October 25, 2018
- Swiss API Manufacturer Bachem Establishes Japanese Subsidiary
October 25, 2018
- GSK to Cover Cost of Rubella Testing and Vaccination for Employees
October 25, 2018
- AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
October 24, 2018
- Meiji Seika Pharma Files Safinamide for Parkinson’s Disease in Japan
October 24, 2018
- Regenerative Medicine Product Market to Reach 225 Billion Yen in 2030: Fuji Keizai
October 24, 2018
- Parexel CEO Sees Bright Future for Japan CRO Market
October 23, 2018
- DS-8201 Shows Overall Response Rate of 15.8% in Patients with Colorectal Cancer in Japan-US PI Study: Daiichi Sankyo
October 23, 2018
- Hisamitsu Begins Japan PII Study of Hyperhidrosis Treatment
October 23, 2018
- Eisai, MSD Begin Joint Information Provisioning for Lenvima in Japan
October 23, 2018
- Mitsubishi Tanabe Teams Up with Bioventure for Novel Antibody Drug Discovery Research in Autoimmune Diseases
October 23, 2018
- Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
October 22, 2018
- Daiichi Sankyo Begins 1st-in-Human Trial for AXL Inhibitor
October 22, 2018
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
